|
|
|
|
|
 |
MARK SCHOENEBAUM is a Senior Managing Director, heads ISI's Health Care Research Team and is ISI's Biotechnology & Pharmaceuticals Analyst. He has been ranked Institutional Investor #1 biotechnology analyst for the past 5 years. In addition, Mark has been Greenwich Associates #1 biotechnology analyst for the past 4 years.
Prior to joining ISI in 2010, Mark spent 2 years at Deutsche Bank as a Managing Director and Senior Biotechnology Analyst. Prior to that, Mark held a similar position at Bear Stearns.
Mark graduated from Indiana University with highest distinction in 1996 with a BA and received an MD from the Johns Hopkins University School of Medicine in 2000.
|
|
